Re-appointment of a Managing Director, subject to approval of the shareholders of the Company in the ensuing AGM.

August 12, 2026 To, To, Listing / Compliance Department Listing / Compliance Department BSE LTD National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Plot No. C/1, Dalal Street G Block Bandra-Kurla Complex, Mumbai- 400 001 Bandra (E), Mumbai- 400 051. SCRIP CODE – 540145 SYMBOL- VALIANTORG Sub: Outcome of the Board Meeting Ref: Regulation 33 and 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the “SEBI Listing Regulations”) Dear Sir / Madam, Pursuant to Regulation 33 and 30 read with Para A, Part A of Schedule III of the SEBI Listing Regulations, as amended, we wish to inform you that the Board of Directors at its Meeting held today i.e. Wednesday, August 12, 2026, inter-alia considered and approved :- 1. The Unaudited Standalone and Consolidated Financial Results (“Financial Results”) for the quarter ended June 30, 2026, based on the recommendation of the Audit Committee, in this regard we enclosed the following as an Annexure A: - Statement showing the Financial Results; and - Limited Review Report of the Statutory Auditors Further, please note that the Company has already made necessary arrangement to publish the Financial Results in the Newspapers as required under Regulation 47 of the SEBI Listing Regulations. 2. Re-appointment of Shri Sathiababu K. Kallada (DIN: 02107652) as the Managing Director of the Company for a term of 3 (Three) years with effect from May 24, 2027 to May 23, 2030, based on recommendation of Nomination and Remuneration Committee and subject to the further approval of the Shareholders of the Company in the ensuing Annual General Meeting. We hereby confirm that Shri Sathiababu K. Kallada is not debarred from holding the office of Director pursuant to any order of SEBI or such other authority. The required details pursuant to SEBI Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 issued on January 30, 2026, are annexed herewith as Annexure-B. 3. The shifting of Registered Office of the Company from 109, 1st Floor, Udyog Kshetra, Mulund Goregaon Link Road, Mulund (W) – 400080, to Plot No. M-7, MIDC, Tarapur, Boisar, Palghar – 401506, Maharashtra, India, subject to the approval of Shareholders of the Company in the ensuing Annual General Meeting. This relocation also involves a change in jurisdiction from the Registrar of Regd. Office:109, Udyog Kshetra, 1st Floor, Mulund Goregaon Link Rd, Mulund West, Mumbai 400080, India. +91 22 6797 6683 • info@valiantorganics.com • www.valiantorganics.com CIN NO.: L24230MH2005PLC151348 Companies, Mumbai I to the Registrar of Companies, Mumbai II (headquartered at Navi-Mumbai), within the State of Maharashtra. In addition to the above, we wish to inform you that, the Corporate Office of the Company is now located at 701-A, Tower-B, Embassy 247 Park, Gandhi Nagar, Vikhroli (West), Mumbai – 400083, Maharashtra, from where the administrative and other corporate functions of the Company shall be carried out. The Meeting of the Board of Directors commenced at 12.35 PM (IST) and concluded at 03.50 PM (IST). Kindly take the same on your record. Thanking You, Yours faithfully, For Valiant Organics Limited Kaustubh Kulkarni Company Secretary ICSI M No: A52980 Encl.: a/a Regd. Office:109, Udyog Kshetra, 1st Floor, Mulund Goregaon Link Rd, Mulund West, Mumbai 400080, India. +91 22 6797 6683 • info@valiantorganics.com • www.valiantorganics.com CIN NO.: L24230MH2005PLC151348 gokhale & sathe (regd.) Annexure A chartered accountants IND IA 304/308/309/311,udyog mandir no.1, 7-c, bhagoji keer marg,mahim, mumbai -400 016,maharashtra,india. Independent Auditor's Limited Review Report on Unaudited Standalone Financial Results of Valiant Organics Limited for the Quarter Ended 30 June 2026 Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board of Directors, Valiant Organics Limited. 1 We have reviewed the accompanying statement of unaudited standalone financial results ("the Statement") of Valiant Organics Limited ('the Company') for the quarter ended 30 June 2026 being submitted by the Company pursuant to the requirement of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements), Regulation 2015 as amended ("Listing Regulations). 2 This Statement, which is the responsibility of the Company's management and approved by the Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 "Interim Financial Reporting" ("Ind AS 34"), prescribed under Section 133 of the Companies Act, 2013 ("the Act") read with relevant rules issued thereunder arid other accounting principles generally accepted in India. Our responsibility is to issue a report on the Statement based on our review. 3 We conducted our review in accordance with the Standard on Review Engagement (SRE) 2410, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity", issued by the Institute of Chartered Accountants of India. This Standard requires that we plan and perform the review to obtain moderate assurance as to whether the financial results are free of material misstatement. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. tel.(off). : +91 022 4348 4242 I email : office@gokhalesathe.in Or gokhale & sathe (regd.) chartered accountants IND IA 4 Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with applicable Indian Accounting Standards specified under section 133 of the Companies Act, 2013 as amended, read with relevant rules issued thereunder and other recognised accounting practices and policies has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 including the manner in which it is to be disclosed, or that it contains any material misstatement. Other Matter 5 Attention is drawn to the fact that the figures for the three months ended 31 March 2026 as reported in these unaudited standalone financial results are the balancing figures between audited figures in respect of the full previous financial year and the published year-to-date figures up to the third quarter of the previous financial year. The figures up to the end of the third quarter of the previous financial year were subject to limited review by us. For Gokhale & Sathe, Chartered Accountants, ICAI Firm Registration No.: 103264W c::: l ;;;;& t::--- Ravindra More Partner ICAI Membership No.: 153666 UDIN: 26153666IGMKCS8423 Date: 12 August 2026 Place: Mumbai •••• Valiant Organics Limited Valiant Organics Addresss -109, Udyog Kshetra, 1st Floor, Mulund Goregaon Link Road, Mulund (W), Mumbai -400 080. Limited CJN :-L24230MH2005PLC151348 ANNEXUREI Statement of Standalone Unaudited Financial Results for the Quarter ended 30th June,2026 Rs. In Lakhs (except EPS) Sr. Particulars Standalone Quarter Ended Year Ended 30-Jun-2026 31-Mar-2026 30-Jun-2025 31-Mar-2026 (Reviewed) (Audited) (Reviewed) (Audited) 1 Income a) Revenue from Operations 23,153.85 21,770.02 20,440.64 73,838.31 b) Other Income 264.20 400.97 107.42 691.48 Total Income 23,418.05 22,170.99 20,548.06 74,529.79 2 Expenses a) Cost of Materials consumed 15,032.08 12,174.24 12,545.95 44,126.75 b) Purchases of stock in Trade 20.25 51.23 14.35 193.64 c) Changes in inventories of Finished Good [Showing first 8,000 characters — download PDF for full document]